|
|
|
| home > white papers > Achieve full compliance with tamper-verification pharma solutions - UPM Raflatac |
|
|
 WHITE PAPERS |
|
UPM Raflatac
|
|
Achieve full compliance with tamper-verification pharma solutions
|
|
UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Biosimilar Drug Development the analytical strategy is keyfactor for your success
Heilbronn/Dortmund March 2019: The generation of analytical data for the comparison between a biosimilar and the originator product is the initial assumption in the development of biosimilars.
Achieving Biosimilarity can be a controversial and complex topic when deciding the right time point and range of analytics.
More info >> |
|
 |
White Papers |
 |
|
High-tech Packaging for High-tech Medicine
West Pharmaceutical Services, Inc.
As more biologics and biosimilars come on to the global pharmaceutical market, they can and will present unique packaging and containment challenges. For materials that are sensitive to glass or that may require larger-dose volumes or custom configurations, cyclic olefin polymers may offer a solution. These novel materials for drug container closure systems can provide a needed alternative to traditional glass containment systems for advanced therapeutics.
More info >> |
|
 |
Industry Events |
 |
The Universe of Pre-filled Syringes and Injection Devices
22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel
PDA’s Universe of Pre-filled Syringes and Injection
Devices has become the must-attend meeting for everyone
working in the field, and is now the world’s largest conference on this subject
More info >> |
|
|
|
